Cipla Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Q1 FY25 results".
Press Release Jul 26 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Cipla
- Cipla: Orchid Pharma partners with Cipla to launch antibiotic Cefepime - Enmetazobactam in India
- Cipla signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India
- Cipla EU to invest an additional EUR 3 million in Ethris
- Press Release Jun 18 2024
- Cipla announces additional investment in Achira
Later from Cipla
- Press Release Oct 29 2024
- Press Release Jan 28 2025
- Press Release May 13 2025
- Press Release Jul 25 2025
- Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla